MOG antibody disease (MOGAD)

MOG antibody disease (MOGAD) is a recently coined neuro-inflammatory condition that preferentially causes inflammation in the optic nerve but can also cause inflammation in the spinal cord and brain. Myelin oligodendrocyte glycoprotein (MOG) is a protein that is located on the surface of myelin sheaths in the central nervous system. While the function of this glycoprotein is not exactly known, MOG is a target of the immune system in this disease. The diagnosis is confirmed when MOG antibodies in the blood are found in patients who have repeated inflammatory attacks of the central nervous system.



 


  • Neuromyelitis Optica Spectrum Disorder (NMOSD)
  • Transverse Myelitis (TM)
  • Acute Disseminated Encephalomyelitis (ADEM)
  • Optic Neuritis (ON)

Related Conference of MOG antibody disease (MOGAD)

April 30-30, 2024

14th International Conference on Womens Health and Cancer Cure

Amsterdam, Netherlands
July 25-26, 2024

20th World Summit on Blockchain Technology

Amsterdam, Netherlands
August 20-21, 2024

11th World Summit on Epilepsy and Bipolar Disorders

Montreal, Canada
September 26-27, 2024

7th Annual Congress on Emergency Medicine and Acute Care

Amsterdam, Netherlands
October 14-15, 2024

11th World Machine Learning and Deep learning Conference

Barcelona, Spain

MOG antibody disease (MOGAD) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in